Effectiveness and persistence of mirabegron as a first-line treatment in patients with overactive bladder in real-life practice.

Mirabegron is an effective first-line therapy for OAB, but has a persistence rate of 39.4% at 12 months. Patients with severe baseline OAB symptoms tended to require add-on therapy during follow-up.